Lomitapide Mesylate Patent Expiration

Lomitapide Mesylate is Used for treating hypercholesterolemia and hyperlipidemia in patients with homozygous familial hypercholesterolemia. It was first introduced by Chiesi Farmaceutici Spa in its drug Juxtapid on Dec 21, 2012.


Lomitapide Mesylate Patents

Given below is the list of patents protecting Lomitapide Mesylate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Juxtapid US10016404 Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects Mar 07, 2025 Chiesi
Juxtapid US10555938 Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects Mar 07, 2025 Chiesi
Juxtapid US5712279 Inhibitors of microsomal triglyceride transfer protein and method Feb 21, 2015

(Expired)

Chiesi
Juxtapid US5712279 Inhibitors of microsomal triglyceride transfer protein and method Feb 21, 2020

(Expired)

Chiesi
Juxtapid US5739135 Inhibitors of microsomal triglyceride transfer protein and method Apr 14, 2015

(Expired)

Chiesi
Juxtapid US6492365 Microsomal triglyceride transfer protein Dec 10, 2019

(Expired)

Chiesi
Juxtapid US7932268 Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects Aug 19, 2027 Chiesi
Juxtapid US8618135 Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects Mar 07, 2025 Chiesi
Juxtapid US9265758 Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects Mar 07, 2025 Chiesi
Juxtapid US9364470 Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects Mar 07, 2025 Chiesi
Juxtapid US9433617 Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects Mar 07, 2025 Chiesi
Juxtapid US9861622 Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects Mar 07, 2025 Chiesi


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳